Andrew Emmett, Managing Director, Science & Regulatory Affairs, speaks about the important regulatory issues facing the industry, specifically PDUFA reauthorization, the FDA and regulation. Also, hear his programming highlights from the Achieving Regulatory Approval and Compliance Track at the upcoming 2012 BIO International Convention.
|
May 10, 2012
|
May 4, 2012
|
May 1, 2012
|
April 27, 2012
|
|
April 26, 2012
|
April 26, 2012
|
April 17, 2012
|
April 13, 2012
|